Arcoma Precision i5 approved for sales in Singapore
2022-07-07 PRESSRELEASE Arcoma Precision i5 approved for sales in Singapore Arcoma has many installations in Singapore and we are, together...
Year: 2022
Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022
Amryt Presents New Analyses from the EASE Phase 3 Trial in Epidermolysis Bullosa at SPD 2022 - Key highlights include...
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
VANCOUVER, British Columbia, July 07, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:...
TScan Therapeutics Appoints Debora Barton, M.D., as Chief Medical Officer
Debora Barton Debora BartonWALTHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company...
XORTX Announces Pre-Phase 3 Meeting Request with US Food and Drug Administration (FDA)
CALGARY, Alberta, July 07, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX...
Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022
SEATTLE and CAMBRIDGE, United Kingdom, July 07, 2022 (GLOBE NEWSWIRE) -- Eliem Therapeutics, Inc. (Nasdaq: ELYM), a clinical-stage biotechnology company...
BioAdaptives, Inc. Introduces PrimiSleep™, An Advanced Sleep-Aid Designed to Harmonize with the Body’s Unique Circadian Rhythm, Delivering Gentle, Sustained, Restorative Sleep With No “Hangover”
PrimiSleep™ Enters Rapidly Growing Global Sleep Aid Market With State-of-the-Art Supplement LAS VEGAS, NV, July 07, 2022 (GLOBE NEWSWIRE) --...
EvolveImmune Therapeutics Appoints Jay Fine, Ph.D., as President of Research and Development
Over 30 Years of Leadership in Drug Discovery and Development, Translational Sciences and Biomarker Research in Immunology, Inflammatory Diseases and...
MediWound Announces Positive Results from its U.S. Phase 2 Pharmacology Study of EscharEx for Debridement of Lower Leg Ulcers
EscharEx Showed Safe, Effective and Rapid Debridement in VLUs and DFUsData Demonstrates EscharEx Reduced Wound Size, Biofilm and Bacterial Burden...
Zynerba Pharmaceuticals Announces Panel Presentation and Poster Presentations at the NFXF International Fragile X Conference
DEVON, Pa., July 07, 2022 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid...
RVL Pharmaceuticals plc Announces Preliminary Second Quarter 2022 UPNEEQ® Net Product Sales Results
-- Expects second quarter 2022 preliminary UPNEEQ net product sales of approximately $8.4 million, representing an increase of 42% from...
Asensus Surgical Announces Installation of Senhance Surgical System in the Department of Gynecology at University Hospital Tübingen
This becomes the 6th Senhance Hospital in GermanyRESEARCH TRIANGLE PARK, N.C., July 07, 2022 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc....
ImmuCell Announces Preliminary, Unaudited Sales Results for Second Quarter of 2022
PORTLAND, Maine, July 07, 2022 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company...
Immuron Receives European Patent Notification on Drug Composition to Treat Clostridioides difficile Associated Disease
MELBOURNE, Australia, July 07, 2022 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on...
ACTO Secures $18M Financing to Accelerate Growth and Strengthen Position as #1 Learning Platform in Life Sciences
ACTO CXO Team (left to right): Kapil Kalra (CCO), John Schultz (CSO), Alison Muller (CMO), Parth Khanna (CEO), Kumar Erramilli...
EVEON announces the launch of the European project INDENEO to develop an innovative delivery system for nose to brain administration of biological and advanced therapy drugs to neonates
EVEON, designer and manufacturer of medical devices for the preparation and delivery of drugs, announces the launch of a European...
Calibre Scientific UK Relocates to State-Of-The-Art Facility in the Advanced Manufacturing Park, Sheffield
LOS ANGELES, July 07, 2022 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the relocation of three key UK...
Chr. Hansen Holding A/S Interim Report Q3 2021/22
Company announcement no. 05/2022 July 7, 2022 Solid Q3 in an uncertain macroeconomic environment Statement by CEO Mauricio Graber: “The...
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer
Genespire appoints Dr. Sabah Sallah as Chief Medical Officer Accomplished executive with extensive preclinical and clinical gene therapy experience joins...
Spexis’ CXCR4 inhibitor balixafortide demonstrates synergistic efficacy in combination with docetaxel in a metastatic prostate cancer preclinical model
ALLSCHWIL, Switzerland, July 07, 2022 (GLOBE NEWSWIRE) -- SPEXIS AG (SIX: SPEX), a clinical-stage biopharmaceutical company, today announced that its...